Abstract
To assess the clinical roles of [18F]fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) performed 2-3 months after completion of concurrent chemoradiotherapy (CCRT), along with pretherapy characteristics, in patients with advanced squamous cell carcinoma of the uterine cervix enrolled in a prospective randomized clinical trial. Posttherapy PET/CT in patients with advanced FIGO stage or positive pelvic or para-aortic lymph node (PALN) defined on pretherapy PET/CT was classified as positive, equivocal, or negative. Overall survival (OS) rates between patients with different PET/CT results are compared. Pretherapy characteristics are examined for association with posttherapy PET/CT results and for prognostic significance in patients with equivocal or negative PET/CT. PET/CT scans (n = 55) were positive, equivocal and negative in 9, 13 and 33 patients, respectively. All patients with positive scans were confirmed to have residual or metastatic disease and died despite salvage therapies. There is a significant OS difference between patients with positive and equivocal scans (P < .001) but not between patients with equivocal and negative scans (P = .411). Positive pretherapy PALN is associated with...Continue Reading
References
Sep 5, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W GrigsbyF Dehdashti
Jun 29, 2004·Cancer·Ting-Chang ChangTzu-Chen Yen
Sep 1, 2004·International Journal of Radiation Oncology, Biology, Physics·Ji-Hong HongSwei Hsueh
Aug 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chyong-Huey LaiTing-Chang Chang
Nov 22, 2007·JAMA : the Journal of the American Medical Association·Julie K SchwarzPerry W Grigsby
Oct 22, 2008·Gynecologic Oncology·Rebecca A BrooksPerry W Grigsby
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration
Jun 30, 2009·Revista española de medicina nuclear·S Sanz-ViedmaA Alavi
Mar 17, 2010·International Journal of Radiation Oncology, Biology, Physics·Chun-Chieh WangJi-Hong Hong
Mar 20, 2010·Cancer Science·Hyuck Jae ChoiYeol Kim
Oct 22, 2011·International Journal of Radiation Oncology, Biology, Physics·Julie K SchwarzPerry W Grigsby
Dec 4, 2014·BMC Health Services Research·Jacoba van der KooyGouke J Bonsel
Jan 17, 2015·Future Oncology·Lindsay HwangKevin Albuquerque
Apr 2, 2015·Gynecologic Oncology·Chun-Chieh WangChyong-Huey Lai
Jul 16, 2015·European Journal of Nuclear Medicine and Molecular Imaging·Shankar SivaKailash Narayan
Apr 29, 2016·Current Oncology·L ElitU Metser
May 11, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Feng-Yuan LiuTzu-Chen Yen
Oct 16, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Andrew ScarsbrookChirag Patel
Jun 14, 2017·Therapeutic Advances in Medical Oncology·Edith Borcoman, Christophe Le Tourneau
Sep 9, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MarthUNKNOWN ESMO Guidelines Committee
Nov 18, 2017·Medicine·Shotaro NaganawaOsamu Abe
Nov 22, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Tzu-Pei SuChyong-Huey Lai
Jul 1, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MarthUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Citations
Sep 8, 2019·European Radiology·Si GaoHongzan Sun
Jul 23, 2019·Journal of Gynecologic Oncology·Yeon Joo KimJoo Hyun Nam
Jan 26, 2021·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Radovan VojtíšekJindřich Fínek
Apr 25, 2020·Journal of Gynecology Obstetrics and Human Reproduction·Sophie KnightXavier Carcopino